Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
67 Cards in this Set
- Front
- Back
pharmacies and other dispensers register with DEA form ______ and ___ for renewal? |
DEA form 224 for inital registration and DEA 224a for renewal |
|
pharmacy registers DEA as _______
|
manufacturer |
|
pharmacy regsiters DEA as ______
|
distributor |
|
how long are DEA 222 forms active for if the ordered drug is not rec'd? |
-form is active for 60 days -if not rec'd after 60 days the item is voided and new order must be placed in order to rec'd da drugz |
|
DEA 222 form1 |
|
|
DEA 222 form2 |
|
|
DEA 222 form3 |
|
|
IL law authorizes who to Rx control substances? |
physicians, residents, podiatrists, veterinarians -within a hospital: interns, residents, foreign-trained MDs using hospital DEA number within dey scope |
|
how long is Rx valid for and what is the supply amt for a C2? |
-90 days from date written -30 day supply |
|
what is the amount of time a prescriber must provide a written Rx for emergency situations that might result in 'loss of life' or 'intense suffering'?` |
|
|
IL requirements for emergency kits |
|
|
limited compounds for office use requirements: |
If any of these is missing, a manufacturer's registration is required |
|
Rph dispenses a drug w/out valid Rx or an authorized refill, the product is ______ |
misbranded |
|
______ is a package that has 'an indicator or barrier to entry which if breach or missing can reasoanably be expected to proivde visible evidence to consumers that tampering has ocurred' |
tamper-resistant packaging |
|
Are examples of what? |
anti-tampering measures |
|
All of the following is included in a ______ means and includes evaluation of Rx drug orders and patient records for:
|
Drug regimen review / Drug utilization review |
|
Duties of a PIC when a pharmacy ceases operations: |
|
|
the PIC must work an average of at least ______ hours per week at each location where he or she is the PIC |
8 hrs |
|
who can check-in control orders arrived at a pharmacy? who would be the best person to do it also? |
anyone can check in controls, but best would be a pharmd |
|
who retains DEA forms for a return to distributor/manufacturer transfer between registrants? |
|
|
agents may prepare a CS Rx for a practitioner's sign but a _____ or ____ cannot act as an agent of a practitioner |
-pharmacist or technician |
|
what is required on label for all CS Rxs |
|
|
what are the inventory requirements? |
must be taken bienially, on any date w/in 2 years of previous biennial inventory
|
|
what are the required contents of inventory record? |
|
|
what is counted in inventory? |
|
|
______ files a copy of the DEA 106 to report _____ _____ |
PIC files DEA 106 to report theft or loss of CS to DPR and DEA. if drug is not scheduled under federal law and only under IL (ex: PSE) not requried to report to the DEA |
|
______ amendement reuired Rx drugs to contain a warnign that the drugs could be dispensed legally only with an authorization of a helath professional? |
durham-humprhey amendment of 1951 |
|
______amendment requires
|
kefauver-harris amendment of 1962 |
|
_____ amdenement required
|
prescripition drug marketing act and prescripition drug amdents of 87, 92 |
|
if a rph misfills a Rx, the product that is dispensed is not supported by a valid rx or authorized refill it is ______ |
misbranded |
|
-_____- requires the existance of a valid, doctor-patient-pharmd relationship. a doctor must presribe or order the compounded product for a patient in order for the pharmacist to ______ |
compounding...to compound |
|
compoudning a product for otc sales in considered |
manufacturing |
|
conditions when it is OK to compound |
|
|
IL permission for compounding for office use rules/ office use compounding |
|
|
an OTC product except (a dermatological, dentifrice, insulin, lozenge) not packaged in a tamper-resistant package is_____ |
adulterated |
|
_____articles recognized in official USP/NF main use is the dx, cure, mitigation, tx or prevention of disease in man or animals by the FDA and affecting any structure or any function |
Drugs |
|
when can a rph administer drugs and what route? |
in the context of patient eduction a rph can adminster oral, topical, injectable, and inhalation products |
|
what groups can rph vaccinate? |
|
|
____ means the interpretation, evaluation, implementaiton of a Rx drug order, including the prepartion and delivery of a drug or device to a pt or pt's agent in a suitable container with approriate labels for use by a patient |
dispensing |
|
the organization responsible for overseeing the selection of a nonproprietary name for a new drug is the |
USAN - United States Adopted Name of the American Medical Association |
|
what is the USP-NF? |
Contains pharmacopeial standards for medicines, dosage forms, drug substances, excipients, medical devices, and dietary supplements. It is a combination of the United States Pharmacopeia (USP) with monographs for drug substances & preparations and the National Formulary (NF) with monographs for excipients. Dietary supplements and ingredients appear in a separate section of the USP. |
|
the consumer product safety commision is responsible for what particular act? |
poison prevention packaging act |
|
A female patient that appears to be a minor comes to the pharmacy to purchase Plan B One Step® without a prescription. The pharmacist requests proof of age, and the patient states that she left her identification at home. The pharmacist should: a.Go ahead and sell the Plan B as requested. b. Refuse to sell the Plan B. c. Call the patient’s parents to obtain permission to sell Plan B, and if authorized, go ahead and sell it. d. Ask the patient how old she is, and if she replies “17”, go ahead and sell it. |
a. go head and sell plan b as requested |
|
permission to not use a child-reistant closure on all prescripition may be made by the: rph, prescriber, patient? |
patient only |
|
small group of healthy subjects rec drug; eval of tox, PK, and pharmacologic properites; assessment of safety of drugs in humans |
phase 1 |
|
drug is given to a larger gorup (100 or more) of patients iwth the disease or stms of the condition claimed to be treated by the drug; determine effectiveness and obtain info about dosing relative safety and adverse effects |
phase 2 |
|
drug given to large group of patients (sometimes thousands) in several geographical lcoations as part of controlled clinical trials; obtain data concerning drugs effectiveness compared to placebo; most studies are double blinded |
phase 3 |
|
post-marketing surveillance - monitor use of drug for additional info regarding safety and effectiveness. manufaturer collets data and submits yearly report to FDA. Note: reporting of s/e by health care practitoitioners to FDA or manufacturer is voluntary; reporting by manufactorer of information rec'd is mandatory |
phase 4 studies |
|
when does a C3-5 Rx expire? |
|
|
how can an MD obtain cocaine HCl powder for office use? |
must order all C2 controls like cocaine directly from a supplier using DEA form 222 |
|
used or unused DEA form 222 that are lost or stolen by any purchaser or supplier ______ |
the purchaser or supplier must immediately upon discovery of the theft or less, report it to the Special Agent in Charge of the DEA in the in area of the registrant stating the serial number of each lost form |
|
the operations of the pharmacy and the establishment and maintenance of security provisions are the dual responsibility of the ________ & ______ |
PIC and owner of the pharmacy |
|
what are the activities that a registered pharm tech cannot do? |
|
|
what are the physical requirements of a pharmacy? |
|
|
what are the labeling requirements for future use parenteral sol'ns to which drugs are diluents are added? |
|
|
what are the labeling requirements for non-parenterals packaged for future use? |
|
|
what are the labeling requirements for medictions prepared for immediate use ? |
|
|
what are the labeling requirements for unit dose meds for a specific resident? |
|
|
what are the labeling requirements for single or multi-dose drugs (not sterile soln)
|
|
|
what are the labeling requirements sterile soln with drugs added
|
|
|
what are the labeling requirements for immediate dispensing to a specific patient or resident: single or multi dose drugs
|
|
|
what are the labeling requirements for immediate dispensing to a specific patient or resident: sterile sol'n with drug
|
|
|
what are the tree things required to substitute? is patient consent required? |
patient consent no longer required |
|
what current resource materials must be in a pharmacy preparing sterile parenteral products? |
|
|
what is the 5% rule in relation to wholesaler distribution |
wholesale distributors cannot exceed the sale of rx drugs by a pharmacy to practitioners of 5% of the annual dollar purchases of Rx drugs by the pharmacy and providing the pharmacy maintains a log of sales to practitioners that includes
|
|
what equipment is needed in a licensed pharmacy preparing sterile parenteral products? |
LESTR
|
|
when a medication error occurs ie wrong drug in bottle the product is deemed to be: |
misbranded & adulterated |